IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Ranbaxy Recalls Antibiotic in U.S.

7:30 AM MDT | May 11, 2009

Ranbaxy Pharmaceuticals, a Ranbaxy Laboratories (Gurgaon, India) subsidiary, says it has voluntarily recalled its antibiotic nitrofurantoin capsules from the U.S. market, as certain lots of the product did not conform with approved laboratory specifications. The recall is being coordinated with the U.S. FDA and will be on a retail level, Ranbaxy says. The company says it is looking into the cause of the non-conformity, and that the recalled products are unlikely to produce any serious adverse health effects. However, the company says there is a “remote...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa